List of Tables
Table 1. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation therapy
Table 4. Key Players of Stem Cell Transplant
Table 5. Key Players of Targeted Therapy
Table 6. Key Players of Others
Table 7. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Acute Myeloid Leukemia (AML) Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Regions (2022-2027)
Table 13. Acute Myeloid Leukemia (AML) Therapeutics Market Trends
Table 14. Acute Myeloid Leukemia (AML) Therapeutics Market Drivers
Table 15. Acute Myeloid Leukemia (AML) Therapeutics Market Challenges
Table 16. Acute Myeloid Leukemia (AML) Therapeutics Market Restraints
Table 17. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Acute Myeloid Leukemia (AML) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia (AML) Therapeutics as of 2020)
Table 20. Ranking of Global Top Acute Myeloid Leukemia (AML) Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Acute Myeloid Leukemia (AML) Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Acute Myeloid Leukemia (AML) Therapeutics Product Solution and Service
Table 24. Date of Enter into Acute Myeloid Leukemia (AML) Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Acute Myeloid Leukemia (AML) Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Acute Myeloid Leukemia (AML) Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Bristol-Myers Squibb Company Details
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Product
Table 67. Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Bristol-Myers Squibb Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Acute Myeloid Leukemia (AML) Therapeutics Product
Table 72. Novartis Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Roche Company Details
Table 75. Roche Business Overview
Table 76. Roche Acute Myeloid Leukemia (AML) Therapeutics Product
Table 77. Roche Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Roche Recent Development
Table 79. Genmab Company Details
Table 80. Genmab Business Overview
Table 81. Genmab Acute Myeloid Leukemia (AML) Therapeutics Product
Table 82. Genmab Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Genmab Recent Development
Table 84. GlaxoSmithKline Pharmaceuticals Company Details
Table 85. GlaxoSmithKline Pharmaceuticals Business Overview
Table 86. GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Product
Table 87. GlaxoSmithKline Pharmaceuticals Revenue in Acute Myeloid Leukemia (AML) Therapeutics Business (2016-2021) & (US$ Million)
Table 88. GlaxoSmithKline Pharmaceuticals Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation therapy Features
Figure 4. Stem Cell Transplant Features
Figure 5. Targeted Therapy Features
Figure 6. Others Features
Figure 7. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Acute Myeloid Leukemia (AML) Therapeutics Report Years Considered
Figure 12. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Acute Myeloid Leukemia (AML) Therapeutics Market Share by Players in 2020
Figure 17. Global Top Acute Myeloid Leukemia (AML) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia (AML) Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia (AML) Therapeutics Revenue in 2020
Figure 19. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Acute Myeloid Leukemia (AML) Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Acute Myeloid Leukemia (AML) Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Acute Myeloid Leukemia (AML) Therapeutics Market Share by Region (2016-2027)
Figure 41. China Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Acute Myeloid Leukemia (AML) Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Acute Myeloid Leukemia (AML) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2016-2021)
Figure 63. Genmab Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2016-2021)
Figure 64. GlaxoSmithKline Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia (AML) Therapeutics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

LIST OF FIGURE